Clinical Trials in Foley, Alabama

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

NCT ID: NCT06504446

This clinical trial is studying a new treatment called NOC-110 for adults who suffer from a persistent cough that lasts for more than a year and doesn't have a clear cause. The goal is to see if th...

Registry of the Patient Experience for Carpal Tunnel Release

NCT ID: NCT06071468

This clinical trial, called the Registry of the Patient Experience for Carpal Tunnel Release, is studying the experiences of patients who are planning to have surgery for Carpal Tunnel Syndrome (CT...

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT ID: NCT07000357

This clinical trial is studying a medication called AZD0780 to see if it can help reduce serious heart-related events in patients who have a history of cardiovascular disease or are at high risk fo...

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD

NCT ID: NCT06883305

This clinical trial is investigating the effectiveness and safety of a medication called Tezepelumab for adults with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD). COPD is a ...

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

NCT ID: NCT06899217

This clinical trial is investigating a new medication called CIN-102 (deudomperidone) to see if it can help reduce nausea in adults with idiopathic gastroparesis, a condition that affects how the s...

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

NCT ID: NCT06492291

This clinical trial, called the CORALreef Extension, is studying a medication called enlicitide decanoate in adults who have high cholesterol, also known as hypercholesterolemia. It is an extension...

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

NCT ID: NCT05905926

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

NCT ID: NCT04636814

This clinical trial, known as the PILLAR study, is looking at the effectiveness and safety of a new medication called CHF6001 (also known as Tanimilast) when added to existing treatments for people...

Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

NCT ID: NCT05643534

This clinical trial is studying a new treatment called tenapanor for young people aged 12 to under 18 years who have Irritable Bowel Syndrome with Constipation (IBS-C). The main goal is to see if t...